Amryt Pharma enrols first patient on EB drug trial
Irish company says therapy for skin blistering condition is its prime pipeline candidate
Amryt Pharmaceutical records €4.1m first-half loss
Company also announces granting of US patent for its lead drug Episalvan
Amryt reports €2.5m loss for nine months
Orphan drug development business was subject to reverse takeover by oil and gas group Fastnet
Cantillon: Fastnet chief explains switch to pharma
Fastnet Oil & Gas shareholders to be asked to approve reverse takeover by Amryt Pharma
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices